Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-19

Clinical Trial Update: Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing budesonide capsules, mesalazine granules, and placebo in collagenous colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide capsules (budesonide)
  • Mesalazine Granules (mesalazine)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Collagenous Colitis | Phase 3 | Status: COMPLETED